Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Direct Electromembrane Extraction‐Based Mass Spectrometry: A Tool for Studying Drug Metabolism Properties of Liver Organoids

Direct Electromembrane Extraction‐Based Mass Spectrometry: A Tool for Studying Drug Metabolism... This work introduces a strategy for organoid analysis ‐ direct Electromembrane Extraction based Mass Spectrometry (dEME‐MS) – for coupling liver organoids with mass spectrometry (MS). dEME‐MS comprises electrophoresis of selected small molecules from a culture chamber across an oil membrane, and to a MS compatible solution. This enables clean micro‐extraction of drugs and their metabolites as produced in the liver organoids to capillary liquid chromatography‐mass spectrometry. Applying dEME‐MS, proof‐of‐concept of directly measuring methadone metabolism is demonstrated on adult liver organoids. With 50 liver organoids and 1 μM methadone, methadone metabolism was monitored from 0 to 24 hours (11 time points). All analytes had <0.4 % variance in retention times with >100 measurements. dEME‐MS is capable of automated and selective monitoring of drug metabolism in liver organoids, and could serve as a valuable tool for automated drug discovery efforts. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Analysis & Sensing Wiley

Direct Electromembrane Extraction‐Based Mass Spectrometry: A Tool for Studying Drug Metabolism Properties of Liver Organoids

5 pages

Loading next page...
 
/lp/wiley/direct-electromembrane-extraction-based-mass-spectrometry-a-tool-for-BHgXtGlBK4

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Wiley
Copyright
© 2022 Wiley‐VCH GmbH
eISSN
2629-2742
DOI
10.1002/anse.202100051
Publisher site
See Article on Publisher Site

Abstract

This work introduces a strategy for organoid analysis ‐ direct Electromembrane Extraction based Mass Spectrometry (dEME‐MS) – for coupling liver organoids with mass spectrometry (MS). dEME‐MS comprises electrophoresis of selected small molecules from a culture chamber across an oil membrane, and to a MS compatible solution. This enables clean micro‐extraction of drugs and their metabolites as produced in the liver organoids to capillary liquid chromatography‐mass spectrometry. Applying dEME‐MS, proof‐of‐concept of directly measuring methadone metabolism is demonstrated on adult liver organoids. With 50 liver organoids and 1 μM methadone, methadone metabolism was monitored from 0 to 24 hours (11 time points). All analytes had <0.4 % variance in retention times with >100 measurements. dEME‐MS is capable of automated and selective monitoring of drug metabolism in liver organoids, and could serve as a valuable tool for automated drug discovery efforts.

Journal

Analysis & SensingWiley

Published: Mar 1, 2022

Keywords: drug metabolism; electromembrane extraction; liquid chromatography; mass spectrometry; organoids.

There are no references for this article.